3D-Printed Anatomical Models: Clinicians, Companies Hash Out Issues

Industry, health-care providers and FDA discussed major issues in using additive manufacturing for making anatomical models at the agency's headquarters last month. The findings will be presented in a white paper from the Radiological Society of North America to help FDA figure out how to regulate the technology.

CT Scanner
• Source: Shutterstock

Ensuring repeatability and accuracy in creating 3D-printed anatomical models to help guide surgery and other patient care is a crucial challenge ahead for clinicians, device-makers and third-party service suppliers.

That was a key takeaway from a workshop co-convened last month by US FDA and Radiological Society of North America (RSNA), which highlighted some disagreements between industry and clinicians over proper requirements for 3D printing tools used by clinicians, but much alignment in identifying some

More from Regulation

More from Policy & Regulation

Tariffs Threaten Medtech Innovation And US Position As World Leader, Whitaker Tells Lawmakers

 
• By Brian Bossetta

During his testimony before US senators on the impact of tariffs on critical supply chains, AdvaMed’s Scott Whitaker said the Trump tariffs could jeopardize America’s preeminence in medtech. Other industry experts echoed similar concerns.

Califf Warns Progress May Be In Danger Due To ‘Decimated’ FDA Staff

 
• By Barnaby Pickering

In Vivo spoke to the previous commissioner of the US FDA about recent ongoings at the agency, and where he believes policy should be directed for patient and industry benefit.

What’s A Diagnostic? WHO Wants To Know

 
• By Elizabeth Orr

The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.